CHAIN Biotech appoints new Chief Executive
CHAIN announces the appointment of Dr Matthew Duchars as Chief Executive from the 1st of August 2022 Nottingham, UK- 20th of July 2022 CHAIN Biotechnology has strengthened its senior…
Read MoreCHAIN Biotechnology Ltd was founded by Dr Edward Green in 2014 to develop new Clostridium-based microbial technology for high value healthcare products. CHAIN produces novel live biotherapeutic products (LBPs) for chronic gut-related diseases, such as Inflammatory Bowel Disease (IBD).
At the heart of CHAIN’s unique therapeutic platform is a suite of underpinning technologies including a Clostridia culture collection, a proprietary set of plasmid vectors, engineering biology tools for advanced metabolic engineering, and an advanced in-vivo delivery mechanism using Clostridium.
CHAIN announces the appointment of Dr Matthew Duchars as Chief Executive from the 1st of August 2022 Nottingham, UK- 20th of July 2022 CHAIN Biotechnology has strengthened its senior…
Read More